Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Taking proper precautions can significantly reduce the risk of infections, keep reading as we share some tips.

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

The health department has registered 10 chikungunya cases from March 4-10, prompting it to take preventive measures. The ...

Efavirenz (EFV), brand-named drugs such as Sustiva, is an antiretroviral drug utilized mostly for HIV/AIDS treatment and prevention. Efavirenz is a category of drugs that fall under non-nucleoside ...

Chikungunya is a mosquito-borne viral disease. The illness is marked by fever, severe joint pain, and muscle aches, and currently has no specific antiviral treatment. According to a the Centers ...

Scientists at IIT Roorkee have achieved a major breakthrough by identifying a potential drug for the treatment of chikungunya ...

At a press conference held in Ebène, yesterday, the Minister of Health and Wellness, Mr Anil Kumar Bachoo, has called for public collaboration after the detection of a local case of Chikungunya, ...

Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS.